Agilon Health Rises 10%+ Intraday (and >75% Over Three Weeks) on Analyst Enthusiasm
Bernstein Maintains Market Perform on Agilon Health, Raises Price Target to $3.15
Bernstein Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $3.15
U.S. Small Caps Move Upward; Agilon Health Climbs Highest
Agilon Health Shares Are Trading Higher. The Stock May Be Moving on Continued Strength Following a Citigroup Ratings Upgrade and Price Target Increase Earlier on Friday.
Express News | Agilon Health Shares Are Trading Higher. The Stock May Be Moving on Continued Strength Following a Citigroup Ratings Upgrade and Price Target Increase Earlier on Friday
Here's Why Analysts Just Upgraded Agilon Health (AGL)
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
Agilon Health (AGL) Was Downgraded to a Hold Rating at Stifel Nicolaus
HIMS Downgraded, Agilon Upgraded at Citi in 2025 Health Tech Review
Agilon Health Raised to Neutral From Sell by Citigroup
Citi Upgrades Agilon Health(AGL.US) to Hold Rating, Raises Target Price to $2.25
Express News | Needham Reiterates Hold on Agilon Healthto Hold
Agilon Health Initiated With a Hold at Needham
Express News | Agilon Health Inc : Citigroup Raises to Neutral From Sell; Raises Target Price to $2.25 From $1.75
Goldman Sachs Maintains Agilon Health(AGL.US) With Hold Rating, Announces Target Price $2.5
Worst Performing Stocks for Tax Loss Selling – Wolfe
Forecasting The Future: 10 Analyst Projections For Agilon Health
Macquarie Initiates Agilon Health(AGL.US) With Hold Rating, Announces Target Price $3
Agilon Health Price Target Announced at $3.00/Share by Macquarie